Alison T. Chin
Lawyers
Filters
Editas Medicine $125 million follow-on offering
The stock is listed on the Nasdaq Global Select Market
Gamida Cell $23 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Nikola $100 million follow-on offerings
The shares are listed on Nasdaq
Ormat Technologies $297 million follow-on offering
The stock is listed on the NYSE and Tel Aviv Stock Exchange
Ardelyx $150 million at-the-market offering
The shares are listed on the Nasdaq Global Market
Eli Lilly $4 billion notes offering
The investment-grade notes are due 2026, 2033, 2053 and 2063
Intel $11 billion senior notes offering
The investment-grade offering comprises seven tranches of notes
Roivant Sciences $230 million stock offering
We advised the company on its SEC-registered offering
Pacific Biosciences $201.25 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Deciphera Pharmaceuticals $135.1 million common stock offering
The common stock is listed on the Nasdaq Global Select Market